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This thesis contains work on a large European Union project on (sub)clinical
jaundice (bilirubin >20 pmoTl) in patients aged 16 years or over which was
performed prospectively in 28 European countries both within- and outside the
European Union, to include 10004 patients of which 8032 fulfil led the criteria to be
part of the scientific database. Part of the project was the development of the
electronic diagnostic tool Trialo.
chapter 1 reviews the methods and assesses the systems in use for computer-
based clinical decision aids. For diagnosis making and patient management, a laige
amount of information is exchanged between patient and physician. The compuler
has several inherent capabilities which are suitable for medical problem solving and
can help in the formalization of medical knowledge. The ditferent approaches on
which the 'reasoning engine' is built are based on manipulation of information and
advocate the use of knowledge to construct a solution to a medical problem.
Evaluation of support systems should be made on the accuracy of the program, the
nature of the system, the use of the data and the acceptance by the target users.
Acceptance by physicians depends among other things on ease of use of the user
intedace. The rapid growth of on-line computer communication and the development
of integrated clinical decision support systems and electronic medical records will
induce profound changes in the delivery of health care. still, computer aided
decision making is in its infancy and real support in daily practice is not yet
achieved.
Ghapter 2 introduces the reader into the backgrounds and the purpose of the
Euricterus project. The data obtained in this project provide a baseline for objective
measurement of bedside clinical data to diagnose and sometimes prognosticate
jaundiced patients, whatever the cause. This data is a source of realistic figures on
the diagnostic importance and accuracy ol different symptoms and signs. With this
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database project as starting point, two further European Union successor projects,
one aimed at the development of an electronic medical record for jaundiced patients
(IDMR) and one on the contribution of technology to the diagnosis of jaundice
(ICTEC) have been completed or are in progress.
In chapter 3 the overall results of the Euricterus project are described for one
European country, the Netherlands. Involved were four university and twenty general
hospitals, delivering prospective data on 702 patients. Pancreatic or biliary
carcinoma (2O./"), gallstone disease (13%) and alcoholic liver cirrhosis (10%) were
the most frequent causes of hyperbilirubinaemia while pancreatitis (1.7%), fulminant
liver failure (1.1%) and malaria (1.0%) were the least frequent. The most frequent
symptoms were unwellfeeling, dark urine and anorexia and the most frequent signs
enlarged liver, looks ill and appears wasted. There were ditferences in symptoms
and signs in patients under and above the median bilirubin of 83 pmol/l and also
under and above the median age of 61 years. (Sub)iaundiced patients in general
hospitals were older than in the university hospitals and the frequencies of
symptoms and signs were different. Disease representation was also dilferent and
this in part was due to the relerral praclice of general practitioners.
In chapter 4 severity of disease was assessed in 1015 Euricterus cirrhosis patients
w1h the Campbell-Child and Pugh-Child scores as well as with ascites presence
and degree and a new ascites-nutritional state (ANS) score (based on two Child'
Turcotte variables, no laboratory parameters). Ascites was found in 70% of the
patients and poor nutritional state in nearly half. The median Campbell-Child and
Pugh-Child scores (5-15) were both 1 1 . Analysis of the variable limits, variable score
ranges and classes A, B and C of the Campbell-Child and Pugh-Child classifications
showed different class outcomes to be caused by design ditferences in score
ranges. The ANS score correlated equally well with both the Campbell-Child ancj the
pugh-Child scores. The results of Campbelland Pugh-Child scores being equal(and
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not universally available.
Chapter 5 deals with the relation of the protocol aboratory findings in the 1015
Euricterus cirrhosis patients (chapter 4) to the severity assessments of ascites
absence or presence (ANY), ascites degree (ADeg), ascites-nutritional state (ANS),
Campbell-Child and Pugh-Child scores. Albumin had the strongest correlation with
all five severity assessment methods, followed by prothrombin time, plasma
water/total protein, whole blood water (males), AST/ALT ratio, white blood cell
corpuscles and bilirubin. Also after division of the patients in the liver cirrhosis
categories alcoholic, non-alcoholic and with hepatocellular carcinoma, albumin
appeared (of the variables tested) to be the prime laboratory parameter in cirrhosis
severity assessment.
ln chapter 6 the Mayo clinic prognostic model risk scores and survival estimates and
the Pugh-Child-PBC scores and classes were calculated in '143 Euriclerus primary
biliary cirrhosis (PBC) patients. The median estimated suruival of this PBC
population (Mayo) was 14% at 5 years. Pugh-Child-PBC and Mayo Clinic scores
correlated strongly (r=0.87) and all Mayo and Pugh variables correlated with both
Mayo risk score R and Pugh score P. The conclusion was that Mayo 1-7 year
suruival estimates could be atfixed to Pugh scores, delivering an easy assessment
method for the most impoilant period for therapeutic decisions. The need to validate
these results was stressed.
In chapter 7 the Euricterus protocol laboratory parameters in 143 PBC patients were
related to the Pugh-Child-PBC and Mayo model scores (chapter 6). A significant
correlation ivas found between both Mayo and Pugh scores and total protein/plasrna
water and AST/ALT ratio and the Mayo and Pugh laboratory variables albumin,
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bilirubin and prothrombin time. The peak values of ALT, AST, ALp and LDH all were
in Pugh scores 7 to g and Mayo scores 6.1 to 7.8. The six patients with white blood
cefl corpuscles above 12 xl}st all had ascites. The conclusion was that in this pBC
population albumin, bilirubin, prothrombin time, total protein/plasma water and
AST/ALT ratio were all related to the severity of disease and prognosis.
In chapter 8 the use of the Euricterus electronic diagnostic tool Trialo, which is
based on data derived from the Euricterus database, is exemplified with the 143
Euricterus PBC patients (chapters 6 and 7). Trialo delivers diagnostic probabilities
based on Bayes' theorem and TrialAlgorithm. The diagnostic probability of pBC was
mentioned with Bayes in 86% and with Trial Algorithm in 91% ol the patients. In the
patients who did not have PBC as sole diagnosis, non-alcoholic active liver disease
and pancreatic or biliary carcinoma were the leading otherfirst diagnoses. pBC was
mentioned by the tool in all patients with a pugh-child-pBC score 10 or higher
(advanced disease). The conclusion was that the electronic tool Trialo was able to
identify PBC as a diagnostic probability in the vast majority of this pBC patient
group.
In chapter 9 the diagnostic accuracy of the physicians, working diagnosis (pwD)
was compared with the Euricterus electronic diagnostic tool Trialo in a random
sample of the Dutch Euricterus patients (chapter 3), in an independent prospective
database derived from patients in three general hospitals in the Netherlands and in
an independent retrospective database from one Dutch hospital. The accuracies of
both PWD and Trialo showed no differences between the three databases and
pooled results ol 416 patients were presented. The accuracy of pwD was about
80% and for Bayes and Trial Algorithm (chapter 8) only slightly less. The conclusion
was that Trialo can strengthen lhe physician's judgment and that it delivers a
(sub)icterus diagnostic disease probability at nearly consultant level.
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